Commentary on: Abiraterone Plus Prednisolone in Metastatic, Castration-sensitive Prostate Cancer

被引：0
|
作者：
Struss, Werner J. [1 ]
Black, Peter C. [1 ]
机构：
[1] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC, Canada
来源：
UROLOGY | 2017年 / 109卷
关键词：
THERAPY;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [21] Emerging therapies in metastatic castration-sensitive and castration-resistant prostate cancer
    MacVicar, Gary R.
    Hussain, Maha H.
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (03) : 252 - 260
  • [22] Abiraterone or docetaxel in men with metastatic castration-sensitive prostate cancer: A pooled analysis of castration resistance-free survival and toxicity.
    Helou, Joelle
    Catton, Charles N.
    Bauman, Glenn
    Fazelzad, Rouhi
    Raphael, Jacques
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [23] Sequential ADT and abiraterone acetate plus prednisone versus combined ADT with abiraterone acetate plus prednisone for metastatic castration-sensitive prostate cancer: A propensity score-matched study.
    Yang, Zhenyu
    Zhao, Diwei
    Wang, Jun
    Long, Xingbo
    Chen, Dong
    Zhou, Fangjian
    Li, Yonghong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] First-line Therapy for Metastatic Castration-sensitive Prostate Cancer
    Lau, Y. H.
    Wan, L. Y.
    Lam, M. H. C.
    HONG KONG JOURNAL OF RADIOLOGY, 2022, 25 (03): : 244 - 245
  • [25] A TITAN step forward: apalutamide for metastatic castration-sensitive prostate cancer
    Kwon, Daniel Hyuck-Min
    Friedlander, Terence
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [26] The cost impact of disease progression to metastatic castration-sensitive prostate cancer
    Quoc-Dien Trinh
    Chaves, Leonardo Passos
    Feng, Qi
    Zhu, Julia
    Sandin, Rickard
    Abbott, Thomas
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (05): : 544 - 554
  • [27] Review of Radium-223 and Metastatic Castration-Sensitive Prostate Cancer
    Dandapani, Savita V.
    Wong, Jeffrey
    Twardowski, Przemyslaw
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2020, 35 (07) : 490 - 496
  • [28] Current Systemic Therapy in Men with Metastatic Castration-Sensitive Prostate Cancer
    Grisay, Guillaume
    Lavaud, Pernelle
    Fizazi, Karim
    CURRENT ONCOLOGY REPORTS, 2024, 26 (05) : 488 - 495
  • [29] Prognostic Significance of Time to Castration Resistance in Patients With Metastatic Castration-sensitive Prostate Cancer
    Miyake, Hideaki
    Matsushita, Yuto
    Watanabe, Hiromitsu
    Tamura, Keita
    Motoyama, Daisuke
    Ito, Toshiki
    Sugiyama, Takayuki
    Otsuka, Atsushi
    ANTICANCER RESEARCH, 2019, 39 (03) : 1391 - 1396
  • [30] Transcriptomic Heterogeneity of Metastatic Disease Timing within Metastatic Castration-Sensitive Prostate Cancer
    Sutera, P.
    Shetty, A.
    Hakansson, A.
    Van der Eecken, K.
    Song, Y.
    Liu, Y.
    Fonteyne, V.
    Verbeke, S.
    Song, D.
    Ross, A. E.
    Feng, F. Y.
    Gillessen, S.
    Attard, G.
    James, N.
    Lotan, T. L.
    Davicioni, E.
    Sweeney, C.
    Tran, P. T.
    Deek, M. P.
    Ost, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E261 - E262
12345